Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian R Engwerda

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Clinical & Translational Immunology|February 28, 2018
Rapid loss of group 1 innate lymphoid cells during blood stage <i>Plasmodium</i> infectionSusanna S Ng, Fernando Souza-Fonseca-Guimaraes, Fabian de Labastida Rivera, et al.
JCI Insight|October 5, 2016
Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host diseaseLaëtitia Le Texier, Katie E Lineburg, Benjamin Cao, et al.
Nature Immunology|October 13, 2020
Transcriptome dynamics of CD4<sup>+</sup> T cells during malaria maps gradual transit from effector to memoryMegan S F Soon, Hyun Jae Lee, Jessica A Engel, et al.
Clinical & Translational Immunology|June 8, 2026
Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet-induced obesityYizhuo Wang, Divya Ramnath, Kaustav Das Gupta, et al.
Science Immunology|July 25, 2017
Eomesodermin promotes the development of type 1 regulatory T (T<sub>R</sub>1) cellsPing Zhang, Jason S Lee, Kate H Gartlan, et al.
The Journal of Clinical Investigation|January 3, 2023
IL-10-producing Th1 cells possess a distinct molecular signature in malariaChelsea L Edwards, Susanna S Ng, Fabian de Labastida Rivera, et al.
The Journal of Clinical Investigation|February 14, 2023
IL-10-producing Th1 cells possess a distinct molecular signature in malariaChelsea L Edwards, Susanna S Ng, Fabian de Labastida Rivera, et al.
Cell Reports|February 27, 2020
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral LeishmaniasisRajiv Kumar, Patrick T Bunn, Siddharth Sankar Singh, et al.
Science Translational Medicine|November 26, 2025
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with <i>Plasmodium falciparum</i>Rebecca Webster, Damian A Oyong, Stacey Llewellyn, et al.
Cell|April 3, 2021
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J Mills, Sean J Humphrey, Patrick R J Fortuna, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Clinical & Translational Immunology|February 28, 2018
Rapid loss of group 1 innate lymphoid cells during blood stage <i>Plasmodium</i> infectionSusanna S Ng, Fernando Souza-Fonseca-Guimaraes, Fabian de Labastida Rivera, et al.
JCI Insight|October 5, 2016
Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host diseaseLaëtitia Le Texier, Katie E Lineburg, Benjamin Cao, et al.
Nature Immunology|October 13, 2020
Transcriptome dynamics of CD4<sup>+</sup> T cells during malaria maps gradual transit from effector to memoryMegan S F Soon, Hyun Jae Lee, Jessica A Engel, et al.
Clinical & Translational Immunology|June 8, 2026
Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet-induced obesityYizhuo Wang, Divya Ramnath, Kaustav Das Gupta, et al.
Science Immunology|July 25, 2017
Eomesodermin promotes the development of type 1 regulatory T (T<sub>R</sub>1) cellsPing Zhang, Jason S Lee, Kate H Gartlan, et al.
The Journal of Clinical Investigation|January 3, 2023
IL-10-producing Th1 cells possess a distinct molecular signature in malariaChelsea L Edwards, Susanna S Ng, Fabian de Labastida Rivera, et al.
The Journal of Clinical Investigation|February 14, 2023
IL-10-producing Th1 cells possess a distinct molecular signature in malariaChelsea L Edwards, Susanna S Ng, Fabian de Labastida Rivera, et al.
Cell Reports|February 27, 2020
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral LeishmaniasisRajiv Kumar, Patrick T Bunn, Siddharth Sankar Singh, et al.
Science Translational Medicine|November 26, 2025
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with <i>Plasmodium falciparum</i>Rebecca Webster, Damian A Oyong, Stacey Llewellyn, et al.
Cell|April 3, 2021
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infectionRichard J Mills, Sean J Humphrey, Patrick R J Fortuna, et al.
Pageof 14